Ceruloplasmin (CP)
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Ceruloplasmin (CP)</th>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Relationship</td>
</tr>
<tr>
<td class="label">[Ferroportin](/genes/fpn1)</td>
<td>Iron export complex</td>
</tr>
<tr>
<td class="label">[Transferrin](/proteins/transferrin)</td>
<td>Iron transport</td>
</tr>
<tr>
<td class="label">[Hephaestin](/genes/heph)</td>
<td>Paralog ferroxidase</td>
</tr>
<tr>
<td class="label">[APP](/proteins/app)</td>
<td>Ferroxidase activity</td>
</tr>
<tr>
<td class="label">[Copper ATPases](/proteins/atp7a-protein)</td>
<td>Copper loading</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
<div style="float: right; width: 300px; margin: 0 0 1em 1em; padding: 1em; background: #f8f9fa; border: 1px solid #ddd; border-radius: 8px; font-size: 0.9em;">
<h3 style="margin-top: 0; border-bottom: 1px solid #ccc;">Ceruloplasmin</h3>
<ul style="list-style: none; padding: 0;"> [@patel2000]
<li><strong>Gene:</strong> [CP](/genes/cp)</li> [@kaneko2002]
<li><strong>UniProt:</strong> [P00450](https://www.uniprot.org/uniprot/P00450)</li> [@musci2019]
<li><strong>Molecular Weight:</strong> ~132 kDa</li>
<li><strong>Subcellular Location:</strong> Secreted (plasma), GPI-anchored (brain)</li>
<li><strong>PDB Structures:</strong> [2J5W](https://www.rcsb.org/structure/2J5W), [1KCW](https://www.rcsb.org/structure/1KCW)</li>
</ul>
</div>
Overview
Ceruloplasmin is a multi-copper ferroxidase essential for systemic and brain iron metabolism. Synthesized primarily in the liver as a secreted plasma protein, an alternative GPI-anchored form is produced by [astrocytes](/entities/astrocytes) in the brain. CP oxidizes Fe2+ to Fe3+, enabling iron binding to transferrin for transport and preventing iron-mediated oxidative damage through Fenton chemistry.
Structure
Ceruloplasmin is the major copper-containing protein in plasma, containing 95% of circulating copper:
- Six copper atoms: Three type I coppers (blue), one type II, two type III
- Three plastocyanin-like domains: Sixfold internal sequence repeat
- Iron-binding sites: Multiple sites for substrate Fe2+ binding
- GPI-anchor site: Alternative C-terminus for membrane attachment in brain
The structure forms a triangular arrangement with a central trinuclear copper cluster essential for ferroxidase activity.
Normal Function
Ferroxidase Activity
CP catalyzes the oxidation of Fe2+ to Fe3+:
4 Fe2+ + 4 H+ + O2 -> 4 Fe3+ + 2 H2O
This reaction is critical for:
Iron export: Enables iron loading onto transferrin
Iron distribution: Supports systemic iron transport
Antioxidant protection: Removes pro-oxidant Fe2+Brain Iron Homeostasis
GPI-anchored CP on astrocytes plays a unique role:
- Iron efflux from brain: Works with ferroportin to export iron
- Neuronal iron supply: Generates transferrin-bound iron for [neurons](/entities/neurons)
- BBB protection: Protects [blood-brain barrier](/entities/blood-brain-barrier) from iron toxicity
Copper Transport
CP serves as the major copper transport protein:
- Copper delivery: Carries copper to tissues
- Copper storage: Safe copper sequestration
- Redox buffering: Prevents free copper toxicity
Role in Neurodegeneration
Aceruloplasminemia
Hereditary CP deficiency causes severe neurodegeneration:
- Genetics: Autosomal recessive CP gene mutations
- Clinical triad: Retinal degeneration, diabetes, neurological symptoms
- Brain iron accumulation: Massive iron deposits in basal ganglia
- Onset: Typically 30-50 years of age
- Pathology: Neuronal loss, gliosis, iron-positive inclusions
Wilson's Disease
Copper metabolism disorder with CP involvement:
- Low CP levels: Characteristic diagnostic finding
- Copper-iron interaction: Disrupted iron handling
- Hepatic synthesis: Impaired CP production
Alzheimer's Disease
CP alterations in AD:
CSF ceruloplasmin: Decreased levels correlate with severity
Amyloid binding: CP binds Abeta peptides
Oxidative stress: Reduced ferroxidase activity increases oxidative damage
Iron accumulation: Contributes to AD-related iron dysregulationParkinson's Disease
CP-iron axis in PD:
- Nigral iron accumulation: Exacerbated by low CP activity
- Ferroxidase deficiency: Impaired iron export
- Oxidative stress: Uncontrolled Fe2+ promotes lipid peroxidation
- Dopaminergic vulnerability: High iron demand increases susceptibility
Neurodegeneration with Brain Iron Accumulation (NBIA)
CP dysfunction contributes to NBIA spectrum:
- Secondary aceruloplasminemia: Acquired CP deficiency
- Combined defects: CP-ferroportin complex disruption
- Therapeutic implications: Iron chelation may help
Therapeutic Targeting
Iron Chelation
Treatment approaches for aceruloplasminemia:
- Deferoxamine: Variable efficacy
- Deferasirox: Some clinical benefit
- Deferiprone: Brain-penetrant option
Copper Supplementation
For Wilson's disease-related CP issues:
- Copper histidine: May increase holo-CP levels
- Zinc therapy: Reduces copper loading
Gene Therapy
Emerging approaches:
AAV-CP delivery: Liver-targeted gene therapy
Enzyme replacement: Recombinant CP infusion
Stem cell therapy: Hepatocyte transplantationBiomarker Applications
CP as a diagnostic marker:
- Wilson's disease screening: Low CP is diagnostic
- Iron status assessment: CP reflects iron handling
- Neurodegeneration marker: Decreased in several conditions
Key Interactions
Pathway & Interaction Diagram
Interactive diagram showing CERULOPLASMIN's key relationships in the SciDEX knowledge graph (5 connections shown).
Mermaid diagram (expand to render)
See Also
- [tau-protein](/proteins/tau) — Related [tau](/proteins/tau) kinase substrate in AD
- [amyloid-beta](/proteins/amyloid-beta-protein) — Related APP cleavage product
- [GSK3B](/proteins/gsk3b) — Major kinase in neurodegeneration
- [CDK5](/genes/cdk5) — Another tau kinase
- [BACE1](/entities/bace1) — Beta-secretase in amyloidogenesis
External Links
- [UniProt](https://www.uniprot.org/) - Protein sequence and functional data
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [PDB](https://www.rcsb.org/) - Protein structure data
References
[Unknown, Vasilyev, Ceruloplasmin in neurodegenerative diseases (2022) (2022)](https://doi.org/10.3390/ijms23137272)
[Unknown, Miyajima, Aceruloplasminemia, an iron metabolic disorder (2015) (2015)](https://doi.org/10.1007/s00415-015-7891-3)
[Patel et al., Ceruloplasmin reduces Alzheimer's disease oxidative stress (2000) (2000)](https://doi.org/10.1016/S0891-5849(00)
[Kaneko et al., Ceruloplasmin protects against lipid peroxidation (2002) (2002)](https://doi.org/10.1046/j.1471-4159.2002.01059.x)
[Musci et al., Ceruloplasmin-ferroportin axis in neurodegeneration (2019) (2019)](https://doi.org/10.1007/s10571-019-00705-x)